MVASI bevacizumab 100 mg/4 mL injection concentrated vial

Amgen Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 8abc6fc9b885c3a3
Product Name: MVASI bevacizumab 100 mg/4 mL injection concentrated vial
Artg Id: 297455
Artg Name: MVASI bevacizumab 100 mg/4 mL injection concentrated vial
Sponsor: Amgen Australia Pty Ltd
Company Detail Path: /organization/amgen-australia-pty-ltd
Artg Date: 2020-06-30
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01273-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-01904-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

8abc6fc9b885c3a3

Type

Standard